GSE225869 3 V 0 TEMOZOLOMIDE HUMAN UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE225869 3 V 0 TEMOZOLOMIDE HUMAN UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE225869 3 V 0 TEMOZOLOMIDE HUMAN UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE225869 3 V 0 TEMOZOLOMIDE HUMAN UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE225869 3 V 0 TEMOZOLOMIDE HUMAN UP.

Results found

Linked to

 

Label

Description

 

Gene

DExD-box helicase 52

Gene

notch 2 N-terminal like B

Gene

cytokine receptor like factor 2

Gene

ASNSD1 upstream open reading frame

Gene

armadillo like helical domain containing 3

Gene

solute carrier family 25 member 25

Gene

patched domain containing 1

Gene

ankyrin repeat and LEM domain containing 2

Gene

proline rich nuclear receptor coactivator 2

Gene

tubulin tyrosine ligase like 7

  • Gene

    DExD-box helicase 52


  • Gene

    notch 2 N-terminal like B


  • Gene

    cytokine receptor like factor 2


  • Gene

    ASNSD1 upstream open reading frame


  • Gene

    armadillo like helical domain containing 3


  • Gene

    solute carrier family 25 member 25


  • Gene

    patched domain containing 1


  • Gene

    ankyrin repeat and LEM domain containing 2


  • Gene

    proline rich nuclear receptor coactivator 2


  • Gene

    tubulin tyrosine ligase like 7

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.